Partnering Solutions

31. Novotech Laboratory Services 11/7/2023

    Our bioanalytical services assist our customers in every stage of their molecule development.

32. Oncology CRO Services 6/27/2023

    Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.

33. Your Top Partner For Ophthalmic Drug Development 4/9/2024

    As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.

34. Safe-To-Site Initiative 12/8/2025

    By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.

35. The inSeption Group Difference 5/31/2023

    Discover how inSeption Group distinguishes the right people as the most impactful variable of any outsourcing equation and contributes to the delivery of life-changing therapies.

36. One Home for Sites™ Partnership Program Guide 4/7/2024

    Learn how your organization can become part of One Home for Sites, the only platform that’s bringing the industry together to help sites survive and thrive, along with their patients.

37. Global Site Partnership Network 7/31/2024

    Accelerate your clinical trials with an expansive network of over 2,000 high-quality, trusted clinical trial sites across Australia, New Zealand, United States and Canada. 

38. How Biorasi Optimizes Clinical Solutions 4/26/2019

    Best-in-class processes coupled with industry-leading technology to fight for your trial’s success.

39. Advancing Development And Approval Of Rare/Ultra-Rare Disease Therapies 5/8/2024

    Veristat empowers rare disease therapy with science-driven strategies and trusted expertise, supporting over 350 rare disease projects and preparing 40+ marketing applications in the past five years.

40. Metavate: Automated, Metadata-Driven, Data Transformation 12/10/2025

    Embedded, flexible clinical services model that scales sponsor capacity, standardizes quality delivery, and accelerates clinical development while sponsors retain strategic and operational control.